| The one thousand and one chaperones of the NF-κB pathway F Fusella, L Seclì, C Cannata, M Brancaccio Cellular and Molecular Life Sciences 77, 2275-2288, 2020 | 27 | 2020 |
| Targeting the extracellular HSP90 co-chaperone morgana inhibits cancer cell migration and promotes anticancer immunity L Seclì, L Avalle, P Poggio, G Fragale, C Cannata, L Conti, A Iannucci, ... Cancer Research 81 (18), 4794-4807, 2021 | 25 | 2021 |
| Defining the data gap: What do we know about environmental exposure, hazards and risks of pharmaceuticals in the European aquatic environment? FD Spilsbury, PA Inostroza, P Svedberg, C Cannata, AMJ Ragas, ... Water Research 251, 121002, 2024 | 20 | 2024 |
| Prioritisation of data-poor pharmaceuticals for empirical testing and environmental risk assessment C Cannata, T Backhaus, I Bramke, M Caraman, A Lombardo, ... Environment International 183, 108379, 2024 | 9 | 2024 |
| A database on pharmaceuticals in the environment: What do stakeholders need? C Cannata, R Vidaurre, AMJ Ragas, CTA Moermond Environmental Science & Policy 162, 103946, 2024 | | 2024 |
| D2. 11 Evaluation of the risk for bioaccumulation of APIs in fish via irreversible inhibition of hepatic CYPs T Sikanen, T Pihlaja, R Brown, C Cannata, AN Perkins PREMIER Consortium, 2023 | | 2023 |
| D2. 11 Evaluation of the risk for bioaccumulation of APIs in fish via irreversible inhibition of hepatic CYPs R Brown, AN Perkins, C Cannata | | 2023 |